Breaks Categories: Stock Spotlights

MondayApr 19, 2021 12:57 pm

NetworkNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) to Bring Quality Products to Retail Buyers Across Canada

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), through its wholly owned subsidiary, Pure Extracts Manufacturing Corp., recently entered into a distribution agreement with an important Canadian LP. Under the agreement, the LP will sell Pure Extracts’ exclusive, high-quality cannabis extract products to provincially authorized distributors and retailers throughout Canada by the end of April. In addition, Pure Extracts has submitted an application to Health Canada to amend its license to permit the company itself to sell cannabis extract products to provincially authorized distributors and retailers. “This milestone dovetails perfectly with our recently signed distribution agreement,” said Pure Extracts’…

Continue Reading

FridayApr 16, 2021 2:09 pm

NetworkNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Finalizes Move into US Cannabis Market

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), an innovative genetics-based cannabis company located in Canada, has closed a purchase agreement with the shareholders of Lords of Grasstown Holdings Ltd. in which PACR will acquire all the issued and outstanding shares. Under the arrangement, Pac Roots agreed to pay $50,000 in cash, within 30 days of the closing date, and issue 6 million common shares of the company. Lords of Grasstown traces its origin to the vision of Tyler Hazelwood, the founder and director of the iconic Lords of Gastown brand. “This acquisition marks a major milestone for the company…

Continue Reading

FridayApr 16, 2021 2:09 pm

NetworkNewsBreaks – RYAH Group Inc.’s Products Facilitate Personalized Therapies, Remote Patient Monitoring

RYAH Group, a company developing proprietary technology supporting a data-driven approach to health care, has created a range of smart devices set to disrupt the future of medicine. RYAH Group, which is on a mission to advance the world’s transition to remote-health solutions, has done precisely that with its remote health platform called RYAH MD. “RYAH MD is a service that allows clinicians to remotely monitor and control patients’ dosing regimens with RYAH’s dose-measuring products. It provides necessary information that doctors can analyze to learn how different dosing variables affect outcomes. RYAH MD allows the doctor to recommend parameters on…

Continue Reading

FridayApr 16, 2021 1:50 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Offers Innovative Solution in Multibillion and Growing Market

Predictive Oncology (NASDAQ: POAI), through its Skyline Medical division, is positioned for opportunity in the fluid management systems and accessories market, which is projected to reach $16.1 billion in 2025 from $8.5 billion in 2020, expanding at a CAGR of 13.6%. These figures are according MarketsandMarkets, which cites several growth factors including technological advancements in fluid management systems (https://ibn.fm/rKWZC) (https://nnw.fm/VXHdd). As disposal of waste fluids presents a unique set of challenges for every health care facility, Skyline Medical offers a clear solution. Skyline’s patented and FDA-cleared STREAMWAY System is “the new standard in waste fluid management,” automating the collection, measurement…

Continue Reading

FridayApr 16, 2021 1:11 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) WP1244 Potentially 500X More Potent than Daunorubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company whose lead drug candidate Berubicin has yielded promising results in the treatment of glioblastoma multiforme (“GBM”), has made equally significant strides with its second drug candidate, WP1244. Still currently in development, preclinical work for WP1244 is expected to continue during 2021 and 2022. “WP1244 is a DNA-binding agent believed to be 500-times more potent than daunorubicin in inhibiting tumor cell proliferation,” reads a recent article. “The current target indication for WP1244 includes brain cancers, pancreatic cancers, ovarian cancers and lymphoma. Preclinical studies show high uptake in the brain with antitumor activity.” On the…

Continue Reading

FridayApr 16, 2021 1:10 pm

NetworkNewsBreaks – Healthy Extracts Inc. (HYEX) Eyes Q2 Expansion of Growing Portfolio

Healthy Extracts (OTCQB: HYEX) recently released its full-year 2020 report. In addition to achieving a 71% jump in its revenue on the back of a plant-based industry boom, the company announced it was at an advanced stage of clinical testing that would culminate in the release of a new product in Q2 2021. The proprietary Fuel4Thought Brain Booster product will add to Health Extracts’ portfolio, which has increased thanks to acquisitions. An article on the developments reads, “Healthy Extracts acquired BergaMet NA in 2019, engaged in selling and distributing a full line of proprietary formulations derived from the rare Citrus…

Continue Reading

FridayApr 16, 2021 12:59 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Leverages Niche to Offer Big Data and Value

SRAX (NASDAQ: SRAX), a financial technology company that unlocks insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, has focused on offering big data to companies, as well as ensuring that they draw significant value from that data. SRAX’s efforts address an existing problem: today, most organizations struggle to get value from a lot of the data they have access to because, as a business practice, it is still very much in its infancy. “That’s where SRAX has carved a niche for itself,” reads an article regarding SRAX’s positioning. “Through Sequire, its innovative investor intelligence and communications platform,…

Continue Reading

ThursdayApr 15, 2021 3:14 pm

NetworkNewsBreaks – United Medical Equipment Business Solutions Network Inc. at Forefront to Speed Economic Recovery

United Medical Equipment (“UME,” “UMEBSNI”) is well-positioned to help speed up economic recovery with its FDA-approved COVID-19 rapid test kits. This comes as governments in different parts of the world have expressed interest in rapid testing, citing health and economic benefits. An article on the matter reads, “New York City is wasting no time to leverage the power of this low-cost, high impact option as the city has announced the launch of its Forward Rapid-Test Program. The program will make low-cost rapid testing available to the broader public to support economic recovery by enabling businesses to more safely re-open. The…

Continue Reading

ThursdayApr 15, 2021 12:58 pm

NetworkNewsBreaks – Mohawk Group Holdings Inc. (NASDAQ: MWK) Achieves Significant Growth, Including 62.3% YOY Revenue Increase

Mohawk Group (NASDAQ: MWK), a technology-enabled consumer products company that uses machine learning, natural language processing and data analytics to design, develop, market and sell products, has announced significant growth on multiple fronts with the release of its Q4 and full-year 2020 results. Some of the notable highlights, documented in an article about the company, include increases in the full-year and fourth-quarter net revenue by 62.3% and 61.9%, respectively. “The full-year net revenue grew to $185.7 million from $114.5 million in the full year 2019. The fourth-quarter net revenue grew to $41.5 million from $25.6 million in the fourth quarter…

Continue Reading

ThursdayApr 15, 2021 11:40 am

NetworkNewsBreaks – XPhyto Therapeutics Corp.’s (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) ‘Covid-ID Lab’ Combines Speed of Rapid Screening with Accuracy of PCR Diagnostic

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, is set to launch a solution for improving detection of the virus responsible for the worldwide pandemic. The company recently announced European regulatory approval of its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system. Known as “Covid-ID Lab,” the system is a commercial in-vitro diagnostic device (CE-IVD) designed to help industry professionals and government agencies screen for the virus. XPhyto’s exclusive German diagnostics partner, 3a-diagnostics GmbH, developed Covid-ID Lab to provide rapid, accurate and portable testing capabilities, granting it marketability as a product with increased convenience and decreased operating costs.…

Continue Reading